| Medical and Health Sciences | Lifetime | 19 | IT 1 | 100.00 |
| Medical and Health Sciences | 2021-2025 | 282 | IT 23 | 99.94 |
| Public, Environmental and Occupational Health | Lifetime | 8 | IT 1 | 99.98 |
| Oncology | Lifetime | 7 | IT 1 | 99.99 |
| Epidemiology | Lifetime | 51 | IT 3 | 99.91 |
| Surgery | Lifetime | 108 | IT 4 | 99.91 |
| Pathology and Forensic Medicine | Lifetime | 52 | IT 3 | 99.79 |
| Pulmonary and Respiratory Medicine | Lifetime | 191 | IT 6 | 99.76 |
| Reproductive Medicine | Lifetime | 56 | IT 6 | 99.69 |
| Cancer Research | Lifetime | 105 | IT 3 | 99.44 |
| Medical Physiology | Lifetime | 270 | IT 4 | 99.57 |
| Obstetrics and Gynecology | Lifetime | 95 | IT 7 | 99.39 |
| Genetics | Lifetime | 382 | IT 4 | 99.12 |
| Clinical Pharmacology | Lifetime | 239 | IT 9 | 99.03 |
| Otolaryngology | Lifetime | 62 | IT 3 | 99.06 |
| Pediatrics, Perinatology and Child Health | Lifetime | 531 | IT 6 | 98.44 |
| Endocrinology, Diabetes and Metabolism | Lifetime | 528 | IT 31 | 98.37 |
| Nutrition and Dietetics | Lifetime | 555 | IT 14 | 97.55 |
| Health | Lifetime | 466 | IT 3 | 96.93 |
| Health, Toxicology and Mutagenesis | Lifetime | 742 | IT 10 | 96.42 |
| Dermatology | Lifetime | 587 | IT 24 | 94.89 |
| Hepatology | Lifetime | 727 | IT 56 | 87.48 |
| Medical Biochemistry | Lifetime | 474 | IT 20 | 85.80 |
| Oncology | 2021-2025 | 53 | IT 5 | 99.72 |
| Public, Environmental and Occupational Health | 2021-2025 | 231 | IT 7 | 98.00 |
| Surgery | 2021-2025 | 644 | IT 39 | 94.44 |
| Pulmonary and Respiratory Medicine | 2021-2025 | 631 | IT 38 | 92.49 |
| Epidemiology | 2021-2025 | 864 | IT 48 | 91.37 |
| Health, Toxicology and Mutagenesis | 2021-2025 | 482 | IT 6 | 91.18 |
| Pathology and Forensic Medicine | 2021-2025 | 372 | IT 18 | 86.20 |
| Reproductive Medicine | 2021-2025 | 317 | IT 32 | 76.07 |
| Multiple and Secondary Primary Cancers | Lifetime | 1 | IT 1 | 99.98 |
| Colorectal Cancer Screening and Detection | Lifetime | 3 | IT 1 | 99.98 |
| Cancer, Lipids, and Metabolism | Lifetime | 5 | IT 1 | 99.95 |
| Global Cancer Incidence and Screening | Lifetime | 4 | IT 1 | 99.97 |
| Cancer Risks and Factors | Lifetime | 3 | IT 1 | 99.97 |
| Endometrial and Cervical Cancer Treatments | Lifetime | 8 | IT 2 | 99.84 |
| Esophageal Cancer Research and Treatment | Lifetime | 7 | IT 1 | 99.83 |
| Nutritional Studies and Diet | Lifetime | 9 | IT 1 | 99.96 |
| Ovarian cancer diagnosis and treatment | Lifetime | 8 | IT 2 | 99.90 |
| Alcohol Consumption and Health Effects | Lifetime | 10 | IT 2 | 99.74 |
| Coffee research and impacts | Lifetime | 2 | IT 1 | 99.73 |
| Head and Neck Cancer Studies | Lifetime | 26 | IT 3 | 99.82 |
| Helicobacter pylori-related gastroenterology studies | Lifetime | 36 | IT 2 | 99.67 |
| Liver Disease Diagnosis and Treatment | Lifetime | 104 | IT 6 | 99.81 |
| COVID-19 and healthcare impacts | Lifetime | 34 | IT 6 | 99.00 |
| Nutrition, Genetics, and Disease | Lifetime | 19 | IT 1 | 99.63 |
| Pancreatic and Hepatic Oncology Research | Lifetime | 78 | IT 6 | 99.71 |
| Folate and B Vitamins Research | Lifetime | 40 | IT 1 | 99.17 |
| Genetic factors in colorectal cancer | Lifetime | 70 | IT 2 | 99.65 |
| Smoking Behavior and Cessation | Lifetime | 28 | IT 1 | 99.33 |
| Estrogen and related hormone effects | Lifetime | 77 | IT 1 | 99.55 |
| Gastric Cancer Management and Outcomes | Lifetime | 126 | IT 6 | 99.61 |
| Occupational and environmental lung diseases | Lifetime | 25 | IT 2 | 99.43 |
| Esophageal and GI Pathology | Lifetime | 90 | IT 5 | 99.55 |
| BRCA gene mutations in cancer | Lifetime | 50 | IT 1 | 99.37 |
| Reproductive Health and Contraception | Lifetime | 27 | IT 1 | 99.06 |
| Metabolism, Diabetes, and Cancer | Lifetime | 100 | IT 5 | 99.49 |
| Cervical Cancer and HPV Research | Lifetime | 92 | IT 4 | 99.42 |
| Cholangiocarcinoma and Gallbladder Cancer Studies | Lifetime | 114 | IT 5 | 99.32 |
| Endometriosis Research and Treatment | Lifetime | 83 | IT 15 | 99.28 |
| Consumer Attitudes and Food Labeling | Lifetime | 32 | IT 1 | 99.23 |
| Diet and metabolism studies | Lifetime | 290 | IT 10 | 99.37 |
| Bladder and Urothelial Cancer Treatments | Lifetime | 141 | IT 8 | 99.28 |
| Oral Health Pathology and Treatment | Lifetime | 68 | IT 3 | 99.19 |
| Cancer Diagnosis and Treatment | Lifetime | 208 | IT 16 | 98.70 |
| Childhood Cancer Survivors' Quality of Life | Lifetime | 205 | IT 7 | 98.82 |
| Fatty Acid Research and Health | Lifetime | 140 | IT 5 | 98.57 |
| Potato Plant Research | Lifetime | 80 | IT 4 | 98.33 |
| Gestational Trophoblastic Disease Studies | Lifetime | 33 | IT 3 | 98.45 |
| Nutrition and Health in Aging | Lifetime | 350 | IT 29 | 98.65 |
| Cutaneous Melanoma Detection and Management | Lifetime | 146 | IT 10 | 98.75 |
| Tea Polyphenols and Effects | Lifetime | 88 | IT 4 | 98.17 |
| Cancer-related molecular mechanisms research | Lifetime | 700 | IT 13 | 98.04 |
| Lymphoma Diagnosis and Treatment | Lifetime | 548 | IT 37 | 98.61 |
| Pancreatitis Pathology and Treatment | Lifetime | 357 | IT 29 | 98.28 |
| Health disparities and outcomes | Lifetime | 377 | IT 3 | 98.44 |
| Global Health Care Issues | Lifetime | 223 | IT 5 | 97.97 |
| Obesity, Physical Activity, Diet | Lifetime | 539 | IT 4 | 98.74 |
| Phytoestrogen effects and research | Lifetime | 140 | IT 5 | 97.69 |
| Nonmelanoma Skin Cancer Studies | Lifetime | 180 | IT 14 | 97.95 |
| Birth, Development, and Health | Lifetime | 732 | IT 8 | 98.05 |
| Hepatocellular Carcinoma Treatment and Prognosis | Lifetime | 720 | IT 70 | 97.92 |
| Acute Lymphoblastic Leukemia research | Lifetime | 602 | IT 41 | 97.87 |
| Diet, Metabolism, and Disease | Lifetime | 582 | IT 42 | 97.28 |
| Gallbladder and Bile Duct Disorders | Lifetime | 635 | IT 43 | 97.57 |
| Inflammatory mediators and NSAID effects | Lifetime | 527 | IT 30 | 97.07 |
| Antioxidant Activity and Oxidative Stress | Lifetime | 477 | IT 27 | 97.06 |
| Menopause: Health Impacts and Treatments | Lifetime | 139 | IT 6 | 97.14 |
| Thyroid Cancer Diagnosis and Treatment | Lifetime | 462 | IT 71 | 97.49 |
| Breast Cancer Treatment Studies | Lifetime | 941 | IT 55 | 97.43 |
| Climate Change and Health Impacts | Lifetime | 614 | IT 13 | 96.20 |
| Cancer and Skin Lesions | Lifetime | 452 | IT 27 | 96.53 |
| Viral-associated cancers and disorders | Lifetime | 697 | IT 42 | 96.63 |
| Garlic and Onion Studies | Lifetime | 176 | IT 5 | 95.23 |
| Genomics, phytochemicals, and oxidative stress | Lifetime | 526 | IT 20 | 95.65 |
| Metastasis and carcinoma case studies | Lifetime | 700 | IT 40 | 95.63 |
| Carcinogens and Genotoxicity Assessment | Lifetime | 775 | IT 28 | 96.45 |
| Cutaneous lymphoproliferative disorders research | Lifetime | 401 | IT 35 | 96.32 |
| Digestive system and related health | Lifetime | 547 | IT 16 | 95.28 |
| Eosinophilic Esophagitis | Lifetime | 868 | IT 72 | 96.15 |
| Male Breast Health Studies | Lifetime | 46 | IT 5 | 92.22 |
| Skin Protection and Aging | Lifetime | 535 | IT 20 | 95.71 |
| Breast Lesions and Carcinomas | Lifetime | 741 | IT 41 | 95.52 |
| Economic and Financial Impacts of Cancer | Lifetime | 694 | IT 17 | 93.50 |
| Health Promotion and Cardiovascular Prevention | Lifetime | 376 | IT 7 | 93.29 |
| Inflammatory Biomarkers in Disease Prognosis | Lifetime | 795 | IT 59 | 89.69 |
| Nutrition, Health and Food Behavior | Lifetime | 616 | IT 1 | 92.01 |
| Health, Environment, Cognitive Aging | Lifetime | 716 | IT 9 | 91.87 |
| Oral health in cancer treatment | Lifetime | 508 | IT 23 | 90.79 |
| Glutathione Transferases and Polymorphisms | Lifetime | 718 | IT 37 | 91.14 |
| Ectopic Pregnancy Diagnosis and Management | Lifetime | 778 | IT 37 | 91.61 |
| Insurance, Mortality, Demography, Risk Management | Lifetime | 523 | IT 13 | 91.56 |
| Occupational exposure and asthma | Lifetime | 674 | IT 30 | 91.28 |
| Nuts composition and effects | Lifetime | 727 | IT 82 | 86.98 |
| Health and Conflict Studies | Lifetime | 995 | IT 12 | 74.21 |
| Healthcare Systems and Challenges | Lifetime | 740 | IT 9 | 66.10 |
| Nutrition, Health, and Society Studies | Lifetime | 66 | IT 3 | 63.01 |
| Hops Chemistry and Applications | Lifetime | 859 | IT 38 | 55.97 |
| Global Cancer Incidence and Screening | 2021-2025 | 5 | IT 1 | 99.72 |
| Cancer Risks and Factors | 2021-2025 | 3 | IT 1 | 99.70 |
| COVID-19 and healthcare impacts | 2021-2025 | 26 | IT 2 | 99.00 |
| Colorectal Cancer Screening and Detection | 2021-2025 | 33 | IT 6 | 99.14 |
| Climate Change and Health Impacts | 2021-2025 | 203 | IT 6 | 96.48 |
| Global Health Care Issues | 2021-2025 | 142 | IT 6 | 92.64 |
| Nutritional Studies and Diet | 2021-2025 | 441 | IT 30 | 94.86 |
| Multiple and Secondary Primary Cancers | 2021-2025 | 98 | IT 8 | 91.26 |
| Health disparities and outcomes | 2021-2025 | 708 | IT 6 | 91.87 |
| Helicobacter pylori-related gastroenterology studies | 2021-2025 | 396 | IT 33 | 91.29 |
| Cancer, Lipids, and Metabolism | 2021-2025 | 569 | IT 26 | 88.17 |
| Metabolism, Diabetes, and Cancer | 2021-2025 | 571 | IT 47 | 85.83 |
| Nutrition, Genetics, and Disease | 2021-2025 | 396 | IT 19 | 79.65 |
| Phytoestrogen effects and research | 2021-2025 | 364 | IT 12 | 67.30 |
| Wnt/β-catenin signaling in development and cancer | 2021-2025 | 649 | IT 25 | 52.69 |
| Insurance, Mortality, Demography, Risk Management | 2021-2025 | 993 | IT 55 | 35.17 |